Osaic Holdings
RGLS

Osaic Holdings’s Regulus Therapeutics RGLS Stock Holding History

Osaic Holdings’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,005
Closed -$3.51K – 7863
2025
Q1 		$3.51K Buy
2,005
+1,205
+151% +$1.59K ﹤0.01% 6362
2024
Q4 		$1.26K Hold
800
– – ﹤0.01% 6760
2024
Q3 		$1.26K Hold
800
– – ﹤0.01% 6768
2024
Q2 		$1.43K Buy
+800
New +$1.86K ﹤0.01% 6716
2023
Q4 		– Sell
-50
Closed -$68 – 7427
2023
Q3 		$68 Hold
50
– – ﹤0.01% 7259
2023
Q2 		$73 Hold
50
– – ﹤0.01% 7312
2023
Q1 		$42 Hold
50
– – ﹤0.01% 7387
2022
Q4 		$0 Hold
50
– – ﹤0.01% 7389
2022
Q3 		$0 Buy
+50
New +$90 ﹤0.01% 7468

Other funds holding RGLS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings's RGLS Position: Q2 2025 in Review

Osaic Holdings sold out of Regulus Therapeutics (RGLS) in Q2 2025, closing a stake of 2,005 shares — an estimated $3.51K sold.

Osaic Holdings first reported a position in RGLS in Q3 2022 and held it in 9 quarters. The position peaked at $3.51K in Q1 2025. 0 funds tracked by Wall St. Rank hold RGLS as of Q2 2025.

  • Osaic Holdings reported no remaining Regulus Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Osaic Holdings sold 2,005 Regulus Therapeutics shares in Q2 2025, an estimated $3.51K.
  • Osaic Holdings first reported a position in Regulus Therapeutics in Q3 2022 and held it in 9 quarters.
  • Osaic Holdings's Regulus Therapeutics position peaked at $3.51K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q2 2025.

Based on Osaic Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.